Scavenger platelets that store DNA could transform cancer screening Updated on: September 07,2025 Scavenger platelets that store DNA could transform cancer screening Updated on:September 07,2025
Are patients undergoing surgery for early-stage cancer at risk of persistent opioid use? Updated on: September 30,2025 Are patients undergoing surgery for early-stage cancer at risk of persistent opioid use? Updated on:September 30,2025
2000 to 2021 saw increase in incidence of pancreatic adenocarcinoma Updated on: May 21,2025 2000 to 2021 saw increase in incidence of pancreatic adenocarcinoma Updated on:May 21,2025
New medication lowers hard-to-control high blood pressure in people with chronic kidney disease Updated on: September 29,2025 New medication lowers hard-to-control high blood pressure in people with chronic kidney disease Updated on:September 29,2025
New medication reduced high triglyceride levels, improved cholesterol and liver health Updated on: December 18,2025 New medication reduced high triglyceride levels, improved cholesterol and liver health Updated on:December 18,2025
Why a promising ALS drug failed—despite hitting its target Updated on: September 30,2025 Why a promising ALS drug failed—despite hitting its target Updated on:September 30,2025
FDA expands use of Vonvendi for von Willebrand disease Updated on: October 01,2025 FDA expands use of Vonvendi for von Willebrand disease Updated on:October 01,2025
Research highlights unreliable responses from most Amazon MTurk users, except for 'master' workers Updated on: August 09,2025 Research highlights unreliable responses from most Amazon MTurk users, except for 'master' workers Updated on:August 09,2025
Scientists are collecting toenail clippings to reveal radon exposure and lung cancer risk Updated on: November 06,2025 Scientists are collecting toenail clippings to reveal radon exposure and lung cancer risk Updated on:November 06,2025
Study: Iza-bren and osimertinib combination shows 100% response rate in EGFR-mutated lung cancer Updated on: September 29,2025 Study: Iza-bren and osimertinib combination shows 100% response rate in EGFR-mutated lung cancer Updated on:September 29,2025